Salem Investment Counselors Inc Agenus Inc Transaction History

Salem Investment Counselors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$1.96 - $3.14 $196 - $314	100 Added 14.68%	781 $2,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $235 - $347	100 Added 17.21%	681 $2,000
Q4 2021 Feb 15, 2022	BUY	$2.92 - $5.74 $306 - $602	105 Added 22.06%	581 $2,000
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $1,280 - $2,499	476 New	476 $1,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Investment Counselors Inc with notifications on news.